Lack of chemopreventive efficacy of metformin in rodent models of urinary bladder, head and neck, and colon/intestine cancer

Lignende værker

• CHEMOPREVENTIVE EFFICACY OF NAPROXEN AND NO-NAPROXEN IN RODENT MODELS OF COLON, URINARY BLADDER, AND MAMMARY CANCERS
  af: Steele, Vernon E., et al.
  Udgivet: (2009)
• Combination of erlotinib and naproxen employing pulsatile or intermittent dosing profoundly inhibits urinary bladder cancers
  af: Mohammed, Altaf, et al.
  Udgivet: (2019)
• Lack of Effect of Metformin on Mammary Carcinogenesis in Non-Diabetic Rat and Mouse Models
  af: Thompson, Matthew D., et al.
  Udgivet: (2015)
• Use of Biomarker Modulation in Normal Mammary Epithelium as a Correlate for Efficacy of Chemopreventive Agents Against Chemically-Induced Cancers
  af: Lubet, Ronald A., et al.
  Udgivet: (2019)
• Daily or weekly dosing with EGFR inhibitors, gefitinib and lapatinib, and AKT inhibitor MK2206 in mammary cancer models
  af: Lubet, Ronald A., et al.
  Udgivet: (2018)